SRPT
Sarepta Therapeutics Inc
17.50$
-0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -512.4% | – | – | – | – | |
| – | +0.0% | -60.0% | +50.0% | +38.8% | +33.6% | +139.6% | +11.3% | +27.2% | +5.8% | +4.6% | -3.7% | -27.1% | -6.1% | +6.1% | -11.1% | +17.3% | -16.3% | +189.0% | +42.2% | +6.9% | +44.2% | +51.3% | +100.1% | +9.8% | +41.3% | +10.1% | +6.1% | -15.0% | +18.0% | |
| – | – | – | – | – | – | +308.1% | +0.0% | -13.9% | -6.5% | +33.2% | -40.5% | -46.9% | +1,331.1% | +33.5% | -1.3% | -1.6% | +261.5% | +82.8% | +57.9% | -6.7% | +1.7% | +64.5% | +56.8% | +37.5% | +5.4% | +104.5% | -21.7% | +1.0% | -33.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4.9% | +996.3% | -31.1% | +40.5% | -6.3% | -397.5% | – | +257.8% | -35.0% | -82.2% | +1,087.9% | – | – | – | |
| – | +0.0% | +100.0% | +100.0% | -176.3% | – | +237.8% | -139.8% | – | – | – | -125.7% | – | – | -111.9% | – | -176.5% | – | -280.4% | – | -149.3% | – | – | – | – | -117.7% | – | – | – | – | |
| – | +200.0% | +666.7% | -91.3% | +306.6% | +413.7% | -33.5% | -41.0% | -34.7% | +37.1% | -1.0% | +46.3% | -42.8% | +63.8% | -2.0% | +18.0% | -50.3% | +229.7% | +610.6% | -82.0% | +42.1% | +209.0% | +203.3% | -7.3% | +37.9% | -53.2% | -16.2% | +170.8% | +68.2% | -30.6% | |
| – | -600.0% | +420.0% | -80.8% | +119.1% | +1,065.3% | -81.2% | +544.2% | – | -152.4% | – | – | -111.7% | +52.0% | +4.1% | +17.5% | -50.3% | +919.4% | +1,262.5% | – | -1,172.4% | +98.3% | +107.2% | – | -142.5% | – | -311.3% | -84.2% | – | -90.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +19.0% | – | – | – | – | – | |
| – | – | – | – | – | – | +23.5% | +0.0% | – | – | – | – | -76.0% | – | – | – | +451.8% | -18.3% | -28.6% | +25.5% | +178.9% | -3.0% | +59.2% | -100.8% | +10.6% | +61.8% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +4.9% | +4.7% | +5.6% | – | -144.7% | – | -100.6% | – | +18.9% | +4.5% | +0.0% | -100.0% | – | +239,000.0% | |
| – | +366.7% | -98.9% | +4,000.0% | +234.6% | -60.8% | +104.2% | +59.6% | -79.8% | +515.3% | -81.2% | +129.6% | -100.2% | – | -94.8% | +1,200.3% | +452.9% | -18.4% | -28.5% | +41.9% | +155.8% | +134.9% | -40.3% | +21.2% | +6.2% | -17.7% | -58.6% | -46.2% | -0.2% | -234.9% | |
| – | +366.7% | -98.9% | +0.0% | +8,507.8% | -186.1% | – | – | +93.0% | +334.5% | -180.5% | – | -393.1% | – | -139.6% | – | +2,239.8% | -53.1% | -364.7% | – | +523.7% | +1,033.2% | -148.0% | – | +41.3% | -8.1% | -285.7% | – | – | -145.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,006.5% | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.